League Table

by

Fund Name Jun-09 Last 3 mths Last 6 mths Last 12 months YTD Ann. Compound Inception
Equities
Technology
DAFNA LifeScience Select Fund Ltd 8.82% 21.39% 18.52% -0.31% 18.52% 9.76% Jan-04
DAFNA LifeScience Fund Ltd 7.44% 17.00% 15.74% 1.00% 15.74% 24.76% Jan-99
CCI Healthcare Partners LP 5.16% 8.90% 7.71% 16.72% 7.71% 10.66% Jan-01
Open Field Investors Fund 4.57% 14.99% 15.63% 11.45% 15.63% 10.47% Nov-99
FrontPoint Healthcare Horizons Fund* 3.91% 10.23% 7.51% -9.00% 7.51% 10.11% Oct-04
DAFNA LifeScience Market Neutral Fund Ltd 3.51% 10.50% 10.25% 1.87% 10.25% 6.06% Jan-03
Crosslink Partners Fund 3.45% 10.56% 13.84% -8.33% 13.84% 15.16% Sep-99
Seligman Health Spectrum Plus Strategy* 2.93% 10.21% 12.86% 0.53% 12.86% 5.93% Apr-07
Emancipation Capital LP 2.90% 28.85% 21.91% -0.03% 21.91% 10.06% Aug-03
Emancipation Capital Ltd 2.80% 27.80% 21.05% -0.48% 21.05% 10.22% Aug-03
Permal Media & Technology A 2.20% 41.18% 41.11% -28.91% 41.11% 2.42% Sep-89
Seligman Health Spectrum Strategy* 2.15% 7.44% 9.37% 1.44% 9.37% 12.16% Jul-04
Seligman Tech Spectrum Fund LLC* 1.96% 6.64% 21.23% 3.19% 21.23% 13.77% Jul-01
Spinner Global Technology Fund Ltd 1.62% 11.67% 11.90% -7.04% 11.90% 14.51% Oct-93
Camelot Capital LP 1.60% 5.77% 7.14% 2.73% 7.14% 12.71% Jan-94
Advantage Advisors Xanthus Fund LLC 1.29% 3.89% 12.22% -9.12% 12.22% 14.47% May-99
FrontPoint Healthcare Fund* 1.12% 3.64% 3.35% -1.68% 3.35% 7.73% May-03
Armadillo Capital 0.73% 14.90% 25.50% 24.56% 25.50% 17.03% Jan-06
Absolute Return Technology Index 0.73% 7.13% 10.10% -2.16% 10.10% 14.27% Jan-98
Cobia Capital Partners LP 0.65% 14.74% 33.80% 16.65% 33.80% 12.82% Jan-08
Cobia Capital Fund Ltd 0.62% 14.52% 33.34% 16.00% 33.34% 12.44% Jan-08
Galleon Technology OS Fund Class A+ 0.58% -2.68% 1.73% -16.62% 1.73% 16.50% Jul-95
Galleon Omni Technology Fund* 0.56% -2.77% 1.64% -8.17% 1.64% 17.52% Mar-96
Harvest Technology Partners 0.42% 8.09% 19.57% 19.45% 19.57% 14.62% Jan-06
Kayne Anderson Midstream Energy Fund Ltd* 0.30% 22.93% 47.55% -50.44% 47.55% -8.82% Jun-05
Intrepid

Log-in to read this content

Log-in

Subscribe now or start a trial to get all the latest on hedge funds.

Subscribe now or start a trial to view this page.

Why subscribe?

Call us to enquire about subscriptions

+44 (0)20 7779 7339